Bausch Health Companies (TSE:BHC) Stock Price Down 3.8% – Should You Sell?

Shares of Bausch Health Companies Inc. (TSE:BHC) traded down 3.8% during trading on Friday . The stock traded as low as C$8.09 and last traded at C$8.10. 665,687 shares changed hands during mid-day trading, an increase of 22% from the average session volume of 545,133 shares. The stock had previously closed at C$8.42.

Analysts Set New Price Targets

Separately, Jefferies Financial Group raised Bausch Health Companies to a “hold” rating in a research report on Wednesday, July 22nd. Three analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of “Hold”.

Bausch Health Companies Stock Down 3.8%

The company has a debt-to-equity ratio of -1,173.29, a quick ratio of 0.58 and a current ratio of 1.44. The company has a market cap of C$3.03 billion, a price-to-earnings ratio of -2.76, a price-to-earnings-growth ratio of 0.21 and a beta of 0.71. The business has a 50-day simple moving average of C$8.13 and a 200-day simple moving average of C$7.65.

Bausch Health Companies (TSE:BHC) last announced its quarterly earnings data on Wednesday, July 29th. The company reported C$1.79 EPS for the quarter. Bausch Health Companies had a positive return on equity of 87.57% and a negative net margin of 12.02%.The business had revenue of C$4.05 billion during the quarter. On average, equities analysts anticipate that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.